HR Execs on the Move

Afferent Pharmaceuticals

www.afferentpharma.com

 
Afferent Pharmaceuticals, Inc. is a leader in the development of novel, selective drugs for the treatment of a range of debilitating neurogenic disorders. These disorders affect millions of patients who suffer from chronic respiratory and urologic sensory pathologies as well as chronic pain, and who have limited, if any, treatment options. These chronic disorders arise when certain nerve fibers become hyper-sensitized as a result of inflammation, distress, infection or tissue injury, and sometimes remain chronically sensitized for months or even years.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

American Postal Workers Union Health Plan

American Postal Workers Union Health Plan is a Glen Burnie, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

East Tennessee Children's Hospital

East Tennessee Children's Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Knoxville, TN. To find more information about East Tennessee Children's Hospital, please visit www.etch.com

Cerebral

Cerebral is a mental health company dedicated to improving access to treatment for anxiety and depression.

APAC Partners

APAC Partners is a Dyer, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.